Organigram (OGI) to Release Earnings on Tuesday

Organigram (NASDAQ:OGIGet Free Report) is expected to release its earnings data before the market opens on Tuesday, February 11th. Analysts expect Organigram to post earnings of ($0.03) per share and revenue of $48.94 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Organigram (NASDAQ:OGIGet Free Report) last posted its quarterly earnings data on Wednesday, December 18th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%. On average, analysts expect Organigram to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Organigram Price Performance

NASDAQ:OGI opened at $1.68 on Monday. The company has a market capitalization of $211.95 million, a P/E ratio of -4.42 and a beta of 1.00. The business has a fifty day simple moving average of $1.56 and a two-hundred day simple moving average of $1.67. Organigram has a 1 year low of $1.31 and a 1 year high of $2.91.

About Organigram

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Featured Articles

Earnings History for Organigram (NASDAQ:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.